SequelSEC

CDT Equity Inc. CDT

Pharmaceutical Preparations · CIK 0001896212 · Fiscal year ends 1231

Revenue
Unavailable
Fiscal year ended 2026-06-30
Operating income
-$34.85M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

CDT Equity Inc. (CDT) reported net income of -$37.15M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from CDT Equity Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

CDT Equity Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
RevenueUnavailable
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$34.85M
Net income-$37.15M
Research & development$3.36M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$31.49M
Selling & marketingUnavailable

Balance

CDT Equity Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$747.00K
Total assets$126.71M
Current assets$2.94M
Total liabilities$23.62M
Current liabilities$23.35M
Total equity incl. NCI$103.09M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$3.72M

Cash flow

CDT Equity Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$11.48M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$9.41M
Net change in cash-$2.58M
Stock-based compensation$2.19M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

CDT Equity Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.13x
Revenue YoY growthUnavailable
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CDT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-07-15View SEC filing
10-K · Filed 2026-04-15View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q/A · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-08-14View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.